Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Article

Intravenous Nitroglycerin in the Management of Retained Placenta

Chedraui P.A.a,b · Insuasti D.F.a

Author affiliations

aLabor Unit of the Enrique C. Sotomayor Obstetrics and Gynecology Hospital, and bInstitute of Biomedicine, Facultad de Ciencias Médicas, Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador

Related Articles for ""

Gynecol Obstet Invest 2003;56:61–64

Do you have an account?

Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Article

Received: April 23, 2002
Accepted: June 24, 2003
Published online: September 18, 2003
Issue release date: September 2003

Number of Print Pages: 4
Number of Figures: 0
Number of Tables: 3

ISSN: 0378-7346 (Print)
eISSN: 1423-002X (Online)

For additional information: https://www.karger.com/GOI

Abstract

Thirty patients in the third stage of delivery complicated by retained placenta were prospectively managed with intravenous nitroglycerin. We studied the effect of nitroglycerin on the hemodynamics and characteristics of the procedure, and also analyzed labor and maternal and neonatal data. Intravenous nitroglycerin effectively aided the extraction of the retained placenta in all cases. The average procedure time was 5.3 ± 1.1 min, and the dose range was 50–200 µg. Systolic and diastolic blood pressure fell significantly from 111 ± 7.5 to 103 ± 6 mm Hg and from 74 ± 6.7 to 67 ± 6.6 mm Hg, respectively (p < 0.05). Although statistically significant, this was not evident clinically and there were no complications. Intravenous nitroglycerin at a dose of 200 µg or less is safe, effective and predictable in the management of retained placenta and could obviate the need of general anesthesia.

© 2003 S. Karger AG, Basel


References

  1. Abrams J: Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia. Am J Cardiol 1992;70:30B–42B.
  2. Miller RR, Vismara LA, Williams DO, Amsterdam EA, Mason DT: Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure: Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation. Circ Res 1976;39:127–133.
  3. Epstein SE, Kent KM, Goldstein RE, Borer JS, Redwood DR: Reduction of ischemic injury by nitroglycerin during acute myocardial infarction. N Engl J Med 1975;292:29–35.
  4. Chuprun JR, Rappoport RM: Nitroglycerin-induced desensitization of vascular smooth muscle may be mediated through cyclic GMP-disinhibition of phosphatidylinositol hydrolysis. Experientia 1986;43:316–318.
  5. Natuzzi ES, Ursell PC, Harrison M, Buscher C, Riemer RK: Nitric oxide synthase activity in the pregnant uterus decreases at parturition. Biochem Biophys Res Commun 1993;194:1–8.
  6. Sladek SM, Regenstein AC, Lykins D, Roberts JM: Nitric oxide synthase activity in pregnant rabbit uterus decreases on the last day of pregnancy. Am J Obstet Gynecol 1993;169:1285–1291.
  7. Yallampalli C, Garfield RE, Byam-Smith M: Nitric oxide inhibits uterine contractility during pregnancy but not during delivery. Endocrinology 1993;133:1899–1902.
  8. Combs CA, Laros RK: Prolonged third stage of labour: Morbidity and risk factors. Obstet Gynecol 1991;77:863–867.
  9. Dombrowski MP, Bottoms SF, Saleh AA, Hurd WW, Romero R: Third stage of labor: Analysis of duration and clinical practice. Am J Obstet Gynecol 1995;172:1279–1284.
  10. Weeks LR, O’Toole DM: Postpartum hemorrhage: A five year study at Queen of Angeles Hospital. Am J Obstet Gynecol 1956;71:45–50.
  11. Thomas WO: Manual removal of the placenta. Am J Obstet Gynecol 1963;86:600–606.
  12. Besinger RE, Ferguson JE: Consequences of tocolysis: Maternal, fetal and neonatal effects; in Repke JT (ed): Intrapartum Obstetrics. Edinburgh, Churchill Livingstone, 1996, pp 297–318.
  13. Wessen A, Elowsson P, Axemo P, Lindberg B: The use of intravenous nitroglycerin for emergency cervico-uterine relaxation. Acta Anaesthesiol Scand 1995;39:847–849.
  14. Rolbin SH, Hew EM, Bernstein A: Uterine relaxation can be life saving. Can J Anaesth 1991;38:939–940.
  15. Mayer DC, Weeks SK: Antepartum uterine relaxation with nitroglycerin at caesarean delivery. Can J Anaesth 1992;39:166–169.
  16. Bayhi DA, Sherwood CD, Campbell CE: Intravenous nitroglycerin for uterine inversion. J Clin Anesth 1992;4:487–488.
  17. Altabef KM, Spencer JT, Zinberg S: Intravenous nitroglycerin for uterine relaxation of an inverted uterus. Am J Obstet Gynecol 1992;166:1237–1238.
  18. DeSimone CA, Norris MC, Leighton BL: Intravenous nitroglycerin aids manual extraction of a retained placenta. Anesthesiology 1990;73:787.
  19. Peng AT, Gorman RS, Shulman SM, DeMarchis E, Nyunt K, Blancato LS: Intravenous nitroglycerin for uterine relaxation in the postpartum patient with retained placenta. Anesthesiology 1989;71:172–173.
  20. Lowenwirt IP, Zauk RM, Handwerker SM: Safety of intravenous glyceryl trinitrate in management of retained placenta. Aust NZ J Obstet 1997;37:20–24.
  21. Ley SJ, Scheller J, Jones BR, Slotnick N: Intrauterine pressure during administration of nitroglycerin for extraction of retained placenta. Anesthesiol Rev 1993;20:95–97.
  22. Redick LF, Livingston E, Bell E: Sublingual aerosol nitroglycerin for uterine relaxation in attempted external version. Am J Obstet Gynecol 1997;176:496–497.
  23. Lees C, Campbell S, Jauniaux E, Brown R, Ramsay B, Gibb D, Moncada S, Martin JF: Arrest of preterm labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor. Lancet 1994;343:1325–1326.
  24. Fliegner JR, Gronow M: Treatment of pre-term cervical dilatation with glyceryl trinitrate, a nitric oxide donor. Aust NZ J Obstet Gynaecol 1997;37:487.
  25. Jennings RW, MacGillivray TE, Harrison MR: Nitric oxide inhibits preterm labor in the rhesus monkey. J Matern Fetal Med 1993;2:170–175.
  26. Dessard P, d’Halluin G, de Meeus JB: Intravenous nitroglycerin in obstetrics: A new indication. Am J Obstet Gynecol 1998;179:813.
  27. Axemo P, Fu X, Lindberg B, Ulmsten U, Wessen A: Intravenous nitroglycerin for rapid uterine relaxation. Acta Obstet Gynecol Scand 1998;77:50–53.
  28. Bell E: Nitroglycerin and uterine relaxation. Anesthesiology 1996;85:683.
  29. Segal S, Csavoy AN, Datta S: Placental tissue enhances uterine relaxation by nitroglycerin. Anesth Analg 1998;86:304–309.
  30. Diamond J, Marshall JM: A comparison of the effects of various smooth muscle relaxants for the electrical and mechanical activity of rat uterus. J Pharmacol Exp Ther 1969;168:21–30.
  31. Norman J: Nitric oxide and the myometrium. Pharmacol Ther 1996;70:91–100.
  32. Shin Y, Wang K, Kim Y: Effect of nitroglycerin on a pregnant uterine muscle in vitro: A dose-response study. Anesth Analg 1994;78:S391.
  33. Gilstrap LC, Hauth JC, Hankins GD, Patterson AR: Effect of type of anesthesia on blood loss at cesarean section. Obstet Gynecol 1987;69:328–332.
  34. Langevin PB: The practice of using nitroglycerin for uterine relaxation. Anesthesiology 1997;87:716–717.

Article / Publication Details

First-Page Preview
Abstract of Original Article

Received: April 23, 2002
Accepted: June 24, 2003
Published online: September 18, 2003
Issue release date: September 2003

Number of Print Pages: 4
Number of Figures: 0
Number of Tables: 3

ISSN: 0378-7346 (Print)
eISSN: 1423-002X (Online)

For additional information: https://www.karger.com/GOI


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.